DarioHealth Corp. DRIO
3.00 USD -0.03 (-0.99%)
At closeNov 3, 2026, 4:04 PM EST
3.00 0.00 0.00%
After hours · Nov 3, 4:04 PM ET
2.88 Day range 3.09
2.88 52-week range 14.77
- YTD
- -73.64%
- 1 year
- -78.17%
News
prnewswire.com DarioHealth to Report Third Quarter 2026 Results on Thursday, November 12, 2026 Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Nov. 2, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leading artificial…
benzinga.com This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated Buy coverage on DRIO ($6), WATT ($15), PPL ($41), DNTH ($113); PYPD rated Outperform with a $10 target.
benzinga.com BTIG Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $6 BTIG analyst David Larsen initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $6.
benzinga.com DarioHealth Expands Contract With Dario To Add Dario Women, Recently Launched Women's Health Solution Supporting Women Navigating Perimenopause And Menopause Symptoms Contract extension follows benefits realized from Dario's cardiometabolic program and strong employee demand for perimenopause supportNearly 45% of Dario's current book of business is women over age…
prnewswire.com Dario Expands Contract with a Leading Regional Grocery Retailer, Adding Women's Digital Health and Clinical Care Program Contract extension follows benefits realized from Dario's cardiometabolic program and strong employee demand for perimenopause support Nearly 45% of Dario's current book of business is women over age…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pomdoctor (NASDAQ:POM) stock moved upwards by 115.1% to $1.43 during Wednesday's regular session. The market value of their outstanding shares is at $4.9 million. Stablecoin Development…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 42.9% to $3.83 during Tuesday's regular session. Myriad Genetics (NASDAQ:MYGN) shares moved upwards by 36.85% to $5.76. The company's market cap…
prnewswire.com DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs A component study of the independent review by Aon found $5,077 in annual savings and 23.5% fewer inpatient discharges per Dario user with type 2 diabetes versus matched non-users Evaluation of 17…
benzinga.com DarioHealth Secures New Jersey Health Plan Contract Through Amwell Partnership; Dario's Cardiometabolic Suite Launch Set For Q1 2027 Agreement secured through channel partner Amwell significantly expands Dario's reach through its channel distribution strategyProgram for Dario's cardiometabolic suite and provider-backed care…
prnewswire.com Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives Agreement secured through channel partner Amwell significantly expands Dario's reach through its channel distribution strategy Program for Dario's cardiometabolic suite and provider-backed care…
defenseworld.net DarioHealth (NASDAQ:DRIO) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened DarioHealth Corp. (NASDAQ: DRIO - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $7.74…
defenseworld.net Pro Medicus (OTCMKTS:PMCUF) versus DarioHealth (NASDAQ:DRIO) Head to Head Survey Pro Medicus (OTCMKTS:PMCUF - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies…
defenseworld.net Contrasting DarioHealth (NASDAQ:DRIO) and Phreesia (NYSE:PHR) Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses…
benzinga.com Alliance Global Partners Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $12 Alliance Global Partners analyst Scott Henry initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $12.
benzinga.com TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8 TD Cowen analyst Charles Rhyee maintains DarioHealth (NASDAQ:DRIO) with a Hold and lowers the price target from $11 to $8.
seekingalpha.com DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript
marketbeat.com DarioHealth Q2 Earnings Call Highlights DarioHealth NASDAQ: DRIO reported second-quarter 2026 revenue of $5.2 million, down from $5.6 million in the first quarter and $5.4 million a year earlier, as the company continued to shift away from…
zacks.com DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago.- benzinga.com DarioHealth Q2 Adj. EPS $(0.72) Beats $(1.22) Estimate, Sales $5.177M Miss $5.923M Estimate DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(1.22) by 40.98 percent. This is a 82.44 percent increase over losses of $(4.10)…
prnewswire.com DarioHealth Reports Second Quarter 2026 Financial Results Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discontinue certain pharmaceutical-related business Gross margin increased to 62%, compared to 57% in the…
prnewswire.com Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company's…
prnewswire.com DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026 Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Aug. 3, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leading artificial…- benzinga.com DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027 First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evaluation, prescribing and ongoing clinical oversight directly inside Dario's chronic care…
prnewswire.com Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evaluation, prescribing and ongoing clinical oversight directly inside Dario's chronic care platform…
zacks.com DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last? DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down…
benzinga.com DarioHealth Prices Direct Offering Of 3,454,559 Shares At $6.80 Per Share To Long-Term Institutional And New Fundamental Investors A member of the Company's Board of Directors participated in the Offering by purchasing 14,430 shares of the Company's common stock at a purchase price of $6.93 per share. The gross proceeds from the…
prnewswire.com Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor NEW YORK, July 22, 2026…
defenseworld.net Financial Analysis: Echo Therapeutics (OTCMKTS:ECTE) vs. DarioHealth (NASDAQ:DRIO) DarioHealth (NASDAQ: DRIO - Get Free Report) and Echo Therapeutics (OTCMKTS:ECTE - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses…- benzinga.com DarioHealth Selected By Fortune 50 Employer To Offer Its Integrated Digital Cardiometabolic Care Platform DarioHealth Corp. (NASDAQ:DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced
prnewswire.com Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition…
prnewswire.com Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15% DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by…- benzinga.com DarioHealth Enters Agreement With A Major Health Insurer In Arizona Through Its Strategic Channel Partnership With Amwell This opportunity makes Dario's cardiometabolic solution available to the insurer's Administrative Services Only ("ASO") book of business, representing access to hundreds of thousands of covered
prnewswire.com Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic…
benzinga.com DarioHealth Announces That A Top-5 U.S. Health Insurer Has Extended And Expanded Its Partnership By Adding The Company's Hypertension Solution The expansion follows success with Dario's behavioral health offering. The health plan's roll out of Dario's cardiometabolic care significantly increases the addressable population and has the…- benzinga.com DarioHealth Enters Services Agreement With Beluga Health To Deliver Provider-Backed, Digitally-Enabled Model For Care, Population Health And Quality Improvement By combining Dario's multi-condition engagement offering with Beluga's physician-led, 50-state clinical network, the monitoring, detection and treatment of members can happen within one platform.…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com DarioHealth Reports Q1 2026 Results: Full Earnings Call Transcript
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com DarioHealth Q1 Adj. EPS $(0.95) Beats $(1.48) Estimate, Sales $5.584M Beat $5.484M Estimate. DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.48) by 35.81 percent. This is a 60.42 percent increase over losses of $(2.40)…- benzinga.com DarioHealth Announces Publication Of New Peer-Reviewed Research In JMIR Formative Research Demonstrating Improvements In Workplace Functioning Among Participants Using Dario's Digital Behavioral Health Program Findings highlight the role of continuous behavioral support in improving focus, productivity and day-to-day functioning – key priorities for employers and health plansStatistically significant…
- benzinga.com DarioHealth Q4 Adj. EPS $(0.82) Up From ($0.80) YoY DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.82) per share, which is a 2.12 percent decrease over losses of $(0.80) per share from the same period last year.
- benzinga.com Earnings Scheduled For March 19, 2026
- benzinga.com DarioHealth Q4 Sales $5.200M Beat $5.047M Estimate, Net loss $6.460M DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.200 million which beat the analyst consensus estimate of $5.047 million by 3.03 percent. This is a 31.61 percent decrease over sales of $7.604…
- benzinga.com DarioHealth Announces Publication Of New Peer-Reviewed Research In Frontiers In Digital Health Demonstrating Substantial And Sustained Blood Glucose Improvements Among Users Of Dario Platform Findings reinforce that engagement data provide clinical signals directly impacting ROIAnalysis further reveals specific frequency of measurements that drive clinical outcomes and bend the cost…
benzinga.com Dariohealth Announces Increasing Employer And Health Plan Demand For Its Oral GLP-1 Digital Health Solution As oral GLP-1s enter the market with slightly more modest weight and glycemic outcomes than injectable formulations, Dario integrates structured behavioral reinforcement to optimize real-world…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com DarioHealth Publishes Peer-Reviewed Study Titled "The Impact of Digital Intervention Messages Targeting Users With High Blood Pressure Events: Retrospective Real-World Study," In JMIR Cardio. Peer-reviewed JMIR Cardio study demonstrates real-world clinical impact of data-driven digital nudges on hypertension outcomesData-driven engagement translates to lower health risks and downstream…- benzinga.com DarioHealth Announces The Publication Of A New Peer-Reviewed Study In The Journal Of Medical Internet Research Showing Digital Diabetes Platform Cuts Hospitalizations 23% And Healthcare Costs 26% Vs. Usual Care Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual careRepresenting…
- benzinga.com DarioHealth Q3 Adj. EPS $(1.91) Beats $(4.90) Estimate, Sales $5.007M Miss $5.665M Estimate DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(4.90) by 61.02 percent. This is a 46.94 percent increase over losses of $(3.60)…
- benzinga.com Earnings Scheduled For November 13, 2025